NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 18 hours 22 min ago

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Fri, 11/03/2017 - 11:25
Funding Opportunity PAR-18-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
Categories: NIH-Funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Fri, 11/03/2017 - 11:11
Funding Opportunity PAR-18-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought. Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and will include transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied.
Categories: NIH-Funding

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)

Fri, 11/03/2017 - 11:09
Funding Opportunity PA-18-015 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote research on interventions, based in healthcare settings, designed to reduce overscreening for breast, cervical, or colorectal cancers among average-risk older adults. While ongoing efforts to promote screening have been successful, there is growing concern that these tests may be overused, thereby subjecting adults to unnecessary risks. Overscreening older adults may be driven by factors at the individual, healthcare team, healthcare system and community organization levels. Therefore, research is needed both to understand the factors that drive overuse and to develop and test interventions that will reduce overuse in healthcare delivery systems. Research supported by this FOA should propose to intervene at two or more levels, and should measure outcomes at two or more levels, while accounting for interactions that occur between levels. Research supported by this FOA should enhance knowledge and consequences of overscreening to improve the health, independence, and quality of life of older adults. adults.
Categories: NIH-Funding

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)

Fri, 11/03/2017 - 11:07
Funding Opportunity PA-18-014 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage exploratory/developmental research grant applications to: (1) assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; (2) identify structural, systemic, and psychosocial barriers to adherence; and (3) develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized. Applications should focus research questions on at least one of the following: specific cancer type; class of drugs; and/or groups subject to disparities (e.g., elderly populations, members of low socioeconomic groups, racial/ethnic minorities). Research may be focused at the patient (pediatric, adolescent, or adult), patient-caregiver, provider, health care team, or health care delivery system level, and may include intervention studies, observational studies, or mixed-methods studies. Observational studies should emphasize modifiable risk factors for future intervention research.
Categories: NIH-Funding

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Fri, 11/03/2017 - 11:00
Funding Opportunity PAR-18-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
Categories: NIH-Funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Fri, 11/03/2017 - 10:53
Funding Opportunity PAR-18-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought. Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and include transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied.
Categories: NIH-Funding

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)

Fri, 11/03/2017 - 10:49
Funding Opportunity PA-18-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote research on interventions, based in healthcare settings, designed to reduce overscreening for breast, cervical, or colorectal cancers among average-risk older adults. While ongoing efforts to promote screening have been successful, there is growing concern that these tests may be overused, thereby subjecting adults to unnecessary risks. Overscreening older adults may be driven by factors at the individual, healthcare team, healthcare system and community organization levels. Therefore, research is needed both to understand the factors that drive overuse and to develop and test interventions that will reduce overuse in healthcare delivery systems. Research supported by this FOA should propose to intervene at two or more levels, and should measure outcomes at two or more levels, while accounting for interactions that occur between levels. Research supported by this FOA should enhance knowledge and consequences of overscreening to improve the health, independence, and quality of life of older adults.
Categories: NIH-Funding

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)

Fri, 11/03/2017 - 10:46
Funding Opportunity PA-18-004 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage research grant applications to: (1) assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; (2) identify structural, systemic, and psychosocial barriers to adherence; and (3) develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized. Applications should focus research questions on at least one of the following: specific cancer type; class of drugs; and/or groups subject to disparities (e.g., elderly populations, members of low socioeconomic groups, racial/ethnic minorities). Research may be focused at the patient (pediatric, adolescent, or adult), patient-caregiver, provider, health care team, or health care delivery system level, and may include intervention studies, observational studies, or mixed-methods studies. Observational studies should emphasize modifiable risk factors for future intervention research.
Categories: NIH-Funding

Notice of NIMH Participaton in (PA-18-345) NIH Research Project Grant (Parent R01 Clinical Trial Required)

Fri, 11/03/2017 - 03:37
Notice NOT-MH-18-006 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of NIMH Participation in (PA-18-344) NIH Exploratory/ Developmental Research Grant Program (Parent R21 Clinical Trial Required)

Fri, 11/03/2017 - 03:37
Notice NOT-MH-18-005 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NIAMS Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01 and R21 Announcements

Fri, 11/03/2017 - 03:37
Notice NOT-AR-18-008 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NHLBI Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for the NIH Parent R01 Clinical Trial Required Announcement

Fri, 11/03/2017 - 03:37
Notice NOT-HL-17-546 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NIMH Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01 and R21 Announcements

Fri, 11/03/2017 - 03:37
Notice NOT-MH-18-004 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NCCIH Policy for Submission of Parent R01 Applications Proposing Clinical Trials

Fri, 11/03/2017 - 03:37
Notice NOT-AT-18-001 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NIH Research Project Grant (Parent R01 Clinical Trial Required)

Fri, 11/03/2017 - 03:36
Funding Opportunity PA-18-345 from the NIH Guide for Grants and Contracts. The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH's definition of a clinical trial through this funding opportunity announcement.
Categories: NIH-Funding

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)

Fri, 11/03/2017 - 03:36
Funding Opportunity PA-18-344 from the NIH Guide for Grants and Contracts. The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH's definition of a clinical trial through this funding opportunity announcement.
Categories: NIH-Funding

Academic Research Enhancement Award (R15 Clinical Trial Required)

Fri, 11/03/2017 - 03:08
Funding Opportunity PA-18-343 from the NIH Guide for Grants and Contracts. The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students to meritorious research projects, and to strengthen the research environment of the applicant institution.
Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-12-200 Occupational Safety and Health Research (R03)

Thu, 11/02/2017 - 13:40
Notice NOT-OH-18-005 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-13-245 Mentored Research Scientist Development Award (K01)

Thu, 11/02/2017 - 13:17
Notice NOT-OH-18-004 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-12-252 NIOSH Exploratory/Developmental Grant Program (R21)

Thu, 11/02/2017 - 13:10
Notice NOT-OH-18-007 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding